(Q36562015)

14 August 2017

1 reference

title

Myositis specific autoantibodies (English)

1 reference

14 August 2017

1 reference

1 reference

Ira N Targoff

1

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Current Rheumatology Reports

14 August 2017

published in

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

196-203

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-996-0025-3

14 August 2017

exact match

0 references

cites work

The long-term outcome of anti-Jo-1-positive inflammatory myopathies

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-996-0025-3

Polymyositis: an overdiagnosed entity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-996-0025-3

Interstitial lung disease in polymyositis and dermatomyositis

21 January 2018

1 reference

12 December 2020

Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

1 reference

12 December 2020

Antibody to signal recognition particle in polymyositis

1 reference

12 December 2020

Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis

1 reference

12 December 2020

Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen

1 reference

12 December 2020

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies

1 reference

12 December 2020

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

12 December 2020

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

1 reference

12 December 2020

Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations.

1 reference

12 December 2020

Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity

1 reference

12 December 2020

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

1 reference

12 December 2020

Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies

1 reference

12 December 2020

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

1 reference

12 December 2020

Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

1 reference

12 December 2020

Idiopathic inflammatory myopathy: autoantibody update

1 reference

12 December 2020

Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain

1 reference

12 December 2020

Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis

1 reference

12 December 2020

Autoantibodies directed to novel components of the PM/Scl complex, the human exosome

1 reference

12 December 2020

Novel autoantibodies against 7SL RNA in patients with polymyositis/dermatomyositis

1 reference

12 December 2020

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

1 reference

12 December 2020

Myopathy with antibodies to the signal recognition particle: clinical and pathological features

1 reference

12 December 2020

Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma

1 reference

12 December 2020

Analysis of the specificity of anti-PM-Scl autoantibodies

1 reference

12 December 2020

Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis

1 reference

12 December 2020

Autoantibody profiles in the sera of European patients with myositis

1 reference

12 December 2020

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies

1 reference

12 December 2020

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus

1 reference

12 December 2020

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

12 December 2020

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

12 December 2020

Scleromyositis (scleroderma/polimyositis overlap) is an entity

1 reference

12 December 2020

Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres

1 reference

12 December 2020

Jo-1 syndrome with associated poorly differentiated adenocarcinoma.

1 reference

12 December 2020

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis

1 reference

12 December 2020

The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen

1 reference

12 December 2020

Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups

1 reference

12 December 2020

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype

1 reference

12 December 2020

The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy

1 reference

12 December 2020

High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders

1 reference

12 December 2020

Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy.

1 reference

12 December 2020

Patients with antibodies to both PmScl and dsDNA

1 reference

12 December 2020

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

1 reference

12 December 2020

Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies

1 reference

12 December 2020

The association between Mi-2 antibodies and dermatomyositis

1 reference

12 December 2020

Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages

1 reference

12 December 2020

PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome

1 reference

12 December 2020

Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies

1 reference

12 December 2020

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl

1 reference

12 December 2020

Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies

1 reference

12 December 2020

Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease

1 reference

12 December 2020

10.1007/S11926-996-0025-3

Identifiers

DOI

1 reference

14 August 2017

1 reference